724 related articles for article (PubMed ID: 9795306)
1. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
4. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
5. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
6. Stenotrophomonas maltophilia bacteremia in burn patients.
Tsai WP; Chen CL; Ko WC; Pan SC
Burns; 2006 Mar; 32(2):155-8. PubMed ID: 16448762
[TBL] [Abstract][Full Text] [Related]
7. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
9. The emergence of Stenotrophomonas maltophilia as a significant nosocomial pathogen at the University Hospital of the West Indies.
Nicholson AM; Castle D; Akpaka P; Tennant I; Nelson M
West Indian Med J; 2004 Jan; 53(1):17-22. PubMed ID: 15114888
[TBL] [Abstract][Full Text] [Related]
10. The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004.
Jumaa PA; Sonnevend A; Pàl T; El Hag M; Amith R; Trad O
Ann Clin Microbiol Antimicrob; 2006 Dec; 5():32. PubMed ID: 17194302
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia.
Al-Otaibi FE; Kambal AM; Baabbad RA
Saudi Med J; 2004 Jan; 25(1):21-5. PubMed ID: 14758373
[TBL] [Abstract][Full Text] [Related]
12. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated.
Vartivarian SE; Papadakis KA; Anaissie EJ
Arch Intern Med; 1996 Feb; 156(4):433-5. PubMed ID: 8607729
[TBL] [Abstract][Full Text] [Related]
15. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
16. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review.
Lin JN; Lai CH; Chen YH; Lin HL; Huang CK; Chen WF; Wang JL; Chung HC; Liang SH; Lin HH
J Microbiol Immunol Infect; 2010 Feb; 43(1):35-42. PubMed ID: 20434121
[TBL] [Abstract][Full Text] [Related]
17. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
18. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.
Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG
J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070
[TBL] [Abstract][Full Text] [Related]
19. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
20. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
Penzak SR; Abate BJ
Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
